On Friday, US stocks rose with support from the technology sector as traders attempted to recover from a turbulent week.

This week, US Treasury yields and oil prices remained persistently high, while artificial intelligence (AI) concept stocks also suffered declines.

The Nasdaq Composite rose 0.6%, the S&P 500 also gained 0.6%, and the Dow Jones Industrial Average climbed 423 points, or 0.8%.

US President Trump stated that Russian President Putin has agreed to supply diesel to the United States and global markets. Following the announcement, US stocks rose to intraday highs.

Oil prices closed slightly higher on Friday, with US West Texas Intermediate (WTI) crude futures near $92 per barrel and Brent crude futures above $104 per barrel. However, after Trump's statement, oil prices edged lower in after-hours trading.

Elon Musk's space and satellite company SpaceX announced an agreement to acquire a nationwide portfolio of radio spectrum assets, driving SpaceX shares higher.

In contrast, AT&T Inc (NYSE: T), Verizon Communications Inc (NYSE: VZ) and T-Mobile US Inc (NASDAQ: TMUS) shares declined as investors worried the deal could intensify market competition.

On Friday, other tech stocks also rose alongside SpaceX. Software stocks led the gains, with Palo Alto Networks Inc (NASDAQ: PANW) up nearly 5%, while CrowdStrike Holdings Inc (NASDAQ: CRWD) and Palantir Technologies Inc (NASDAQ: PLTR) rose 4% and 3%, respectively.

Microsoft Corp (NASDAQ: MSFT) gained 2%, and fellow "Magnificent Seven" member Amazon.com Inc (NASDAQ: AMZN) also rose 2%.

Outside the tech sector, healthcare stocks also stood out, with Merck & Co Inc (NYSE: MRK) and Gilead Sciences Inc (NASDAQ: GILD) both up nearly 3%.

According to reports, the US National Institutes of Health (NIH) is advancing research on cancer vaccines, and market optimism over this drove vaccine stocks such as Moderna Inc (NASDAQ: MRNA) sharply higher.

On Thursday, tech stocks, especially AI-related shares, were the main drag on the market.

Previously, OpenAI had told investors that its annualized revenue reached $50 billion as of the end of September. Last month, this figure was widely reported as $68 billion, but a person familiar with the matter said the latter also included partners' total revenue.

The Nasdaq fell more than 1% on Thursday, marking its largest single-day drop since mid-August. This was also the second consecutive decline for the tech-heavy index, after it had hit a record high earlier in the week.

Adam Crisafulli of Vital Knowledge wrote: "The sell-off reflects extreme positioning imbalances in the market, which we believe still have room for further adjustment. Therefore, the entire AI-related tech stock sector is unlikely to see a rapid sharp V-shaped rebound."

He added: "As for AI, the main issue is not whether annual recurring revenue (ARR) is calculated on a gross or net basis, but rather: 1) independent frontier AI labs are increasingly becoming an unattractive business model; 2) there are growing signs that the market is beginning to resist the wave of AI-related debt and equity financing."

Although long-term US Treasury yields hit a 24-year high this week, followed by market volatility, all three major indexes were still on track to post gains for the week.

The Dow and Nasdaq each rose less than 1% for the week, while the S&P 500 gained about 1%.

Next week, with banks gradually reporting earnings, US earnings season will kick off in full. In addition, well-known companies such as Johnson & Johnson (NYSE: JNJ) and UnitedHealth Group Inc (NYSE: UNH) will also release results. Both companies plan to report on Tuesday, the same day as Wells Fargo & Co (NYSE: WFC) and Citigroup Inc (NYSE: C).

Michael Monaghan of Founder ETFs is bullish on US stocks through year-end, citing expectations for "strong growth" in corporate earnings. However, he still believes the Middle East conflict and its impact on oil prices could weigh on the market.

This week, Trump has said the United States will not attack Iran before next month's midterm elections, but Monaghan maintains his view. The portfolio manager said the Middle East conflict is "one factor preventing the market from fully reflecting the strength of near-term corporate earnings prospects."

He added: "The market has not yet priced in the risk of a more violent war with more intense military action and the conflict spreading to more countries."